The Current Ratio as of June 2026 (TTM) for Reviva Pharmaceuticals Holdings, Inc. (RVPH) is 3.85

According to Reviva Pharmaceuticals Holdings, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 3.85. This represents a change of 87.60% compared to the average of 2.05 of the last 4 quarters.

Reviva Pharmaceuticals Holdings, Inc. (RVPH) Historical Current Ratio (quarterly & annually)

How has RVPH Current Ratio performed in the past?

The mean historical Current Ratio of Reviva Pharmaceuticals Holdings, Inc. over the last ten years is 3.29. The current 3.85 Current Ratio has changed 11.60% with respect to the historical average. Over the past ten years (40 quarters), RVPH's Current Ratio was at its highest in in the September 2021 quarter at 34.81. The Current Ratio was at its lowest in in the May 2018 quarter at 0.

Reviva Pharmaceuticals Holdings, Inc. (RVPH) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Reviva Pharmaceuticals Holdings, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Reviva Pharmaceuticals Holdings, Inc. (RVPH) Average Current Ratio

How has RVPH Current Ratio performed in the past?

The current Current Ratio of Reviva Pharmaceuticals Holdings, Inc. (RVPH) is greater than its 3-year, less than than its 5-year, and greater than its 10-year historical averages

Reviva Pharmaceuticals Holdings, Inc. (RVPH) Current Ratio vs. Peers

How is RVPH’s Current Ratio compared to its peers?

Reviva Pharmaceuticals Holdings, Inc.’s Current Ratio is greater than Annovis Bio, Inc. (1.27), greater than PolyPid Ltd. (1.78), greater than Celularity Inc. (0.15), greater than BioAtla, Inc. (0.15), less than Actinium Pharmaceuticals, Inc. (5.89), less than Evaxion Biotech A/S (5.85), greater than PDS Biotechnology Corporation (2.26), greater than BioXcel Therapeutics, Inc. (0.62), greater than Tvardi Therapeutics, Inc. (2.25), greater than FibroGen, Inc. (3.61),

Build a custom stock screener for Reviva Pharmaceuticals Holdings, Inc. (RVPH) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Reviva Pharmaceuticals Holdings, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Reviva Pharmaceuticals Holdings, Inc. (RVPH) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Reviva Pharmaceuticals Holdings, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.